PRODUCTS & SERVICES
Grifols product portfolio
Since 1909, Grifols has been dedicated to developing high-quality products and services that enhance the health and well-being of people worldwide. We are committed to listening to and learning from our clients to ensure that their patients receive the best possible treatments.
Our ongoing R+D+i efforts enable us to offer a broad portfolio of innovative products and services, delivered through our main divisions.
Consult here our product catalog:
Select your country or region
- Czech Republic
- Hong Kong SAR
- Nordic Countries
- Taiwan, China
- United Kingdom
- United States
The product information for this country is also available in other languages. Please, Select your preferred language:
- Immunology and Neurology
- Intensive care
- Inclusiv Compounding Portfolio
- Robotics and other compounding devices
Learn more about our 4 divisions:
Research, development, production and marketing of plasma-derived medicines and other innovative solutions to treat patients with chronic, rare, prevalent and, at times, life-threatening diseases. Key products include immunoglobulins, alpha-1 antitrypsin, albumin, clotting factors, and specialty hyperimmune globulins.
Specialized in the research, development, production and commercialization of diagnostic products that span the healthcare continuum–from prevention, screening, diagnosis and prognosis to disease and treatment monitoring–to serve professionals working in transfusion medicine and clinical diagnostics.